Valuation : Diaceutics PLC

Market Cap 126M 171M 147M 138M 236M 16.14B 237M 1.64B 633M 8.27B 641M 627M 26.34B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 118M 160M 138M 130M 221M 15.15B 222M 1.54B 594M 7.76B 602M 588M 24.71B EV / Sales 2026 *
2.53x
EV / Sales 2027 * 2.02x
Free-Float
71.97%
Yield 2026 *
-
Yield 2027 * -
1 day-2.44%
6 months+19.76%
Current year+46.28%
Current year 1.67
Extreme 1.67
2.51
1 year 1.67
Extreme 1.67
2.51
3 years 1.67
Extreme 1.67
2.51
5 years 1.05
Extreme 1.05
2.51
10 years 1.05
Extreme 1.05
2.51
Manager TitleAgeSince
Chief Executive Officer 42 31/12/2023
Director of Finance/CFO - 17/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 30/09/2024
Director/Board Member 42 -
Director/Board Member 42 30/09/2024
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-.--% - - 171M
+5.63%+19.63%+272.64%+1,093.58% 62.05B
-1.92%+1.59% - - 6.07B
+7.99%+12.78% - - 3.43B
+2.83%+0.29%-18.51%+41.39% 3.47B
+1.62%-1.41%-9.91%+113.17% 3.23B
+3.22%-7.16% - - 3B
-2.51%+1.01%-20.76%-24.86% 1.52B
-0.13%+2.77%-44.68%+27.83% 1.33B
Average +1.60%+1.66%+35.76%+250.22% 10.51B
Weighted average by Cap. +4.66%+6.34%+233.66%+954.78%

Financials

2026 *2027 *
Net sales 46.72M 63.27M 54.41M 51.18M 87.38M 5.98B 87.66M 607M 235M 3.06B 238M 232M 9.76B 56.34M 76.31M 65.62M 61.72M 105M 7.22B 106M 732M 283M 3.7B 287M 280M 11.77B
Net income -1.1M -1.49M -1.28M -1.21M -2.06M -141M -2.06M -14.29M -5.52M -72.15M -5.59M -5.47M -230M 1.5M 2.03M 1.75M 1.64M 2.81M 192M 2.81M 19.48M 7.53M 98.39M 7.63M 7.46M 313M
Net Debt -7.78M -10.54M -9.06M -8.52M -14.55M -997M -14.6M -101M -39.06M -510M -39.57M -38.71M -1.63B -12.1M -16.38M -14.09M -13.25M -22.62M -1.55B -22.7M -157M -60.73M -793M -61.52M -60.18M -2.53B
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.485GBP
Average target price
2.130GBP
Spread / Average Target
+43.43%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!